LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2021

Apr 27, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2021-04-24

Reporting Person: Amouyal Philippe (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-24	Common Stock	M	10638	—	Acquired	27006	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-24	Restricted Stock Units	$0	M	10638	Disposed		Common Stock (10638)	Direct

Footnotes

F1: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.

F2: Each restricted stock unit represents a contingent right to receive one share of common stock.